PubRank

J D Bonnet

Author PubWeight™ 21.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst 1991 1.40
2 Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study. J Clin Oncol 1990 1.39
3 Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group. Cancer Invest 1991 1.39
4 Prognostic factors in multiple myeloma. Cancer 1975 1.29
5 Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study. J Clin Oncol 1983 1.04
6 Bronchogenic carcinoma presenting as spontaneous pneumothorax: case reports with review of literature. Cancer 1977 1.03
7 Spontaneous pneumothorax with metastatic malignant melanoma. Chest 1977 0.98
8 Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study. Invest New Drugs 1990 0.95
9 A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study. Cancer 1995 0.93
10 Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study. Cancer 1983 0.91
11 Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Cancer 1976 0.86
12 Bronchial adenoma and the carcinoid syndrome. Ann Surg 1967 0.84
13 Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. Cancer Treat Rep 1984 0.84
14 Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. Arch Intern Med 1974 0.82
15 Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience. J Immunother (1991) 1991 0.82
16 A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group study. Invest New Drugs 1990 0.81
17 Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group study. Am J Med 1984 0.79
18 Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. Cancer Treat Rep 1982 0.78
19 Primary malignant pulmonary tumors in the older patient. Clin Geriatr Med 1985 0.77
20 Tamoxifen therapy and colorectal adenocarcinoma: a Southwest Oncology Group study. Cancer Treat Rep 1985 0.77
21 Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group study. Am J Clin Oncol 1983 0.77
22 Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group study. Invest New Drugs 1994 0.77
23 A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas. Cancer 1986 0.76
24 Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study. Cancer Treat Rep 1987 0.75
25 Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study. Invest New Drugs 1991 0.75
26 Yoshi 864 plus medroxyprogesterone acetate in adenocarcinoma of the kidney: A Southwest Oncology Group Study. Cancer Treat Rep 1982 0.75
27 Evaluation of amonafide in refractory and relapsing multiple myeloma: a Southwest Oncology Group study. Anticancer Drugs 1991 0.75
28 Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764). Cancer Treat Rep 1980 0.75
29 Myeloma and other paraproteinemias. Postgrad Med 1977 0.75
30 Normocytic normochromic anemia. Postgrad Med 1977 0.75
31 Response of advanced breast cancer to two dosage regiments of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962). Cancer Chemother Rep 1973 0.75
32 Management of metastatic lesions of bone. 2. Chemotherapeutic aspects. Postgrad Med 1966 0.75
33 Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study. Cancer Treat Rep 1986 0.75
34 Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group study. Invest New Drugs 1990 0.75
35 Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study. Cancer Treat Rep 1985 0.75
36 Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893). Cancer Chemother Rep 1975 0.75